30 mg dexlansoprazole capsules manufactured at TOB
Sponsors
Takeda
Conditions
Healthy Volunteers
Phase 1
Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants
CompletedNCT03131895
Start: 2017-04-25End: 2017-07-31Updated: 2019-06-14
A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules
CompletedNCT03801148
Start: 2019-01-10End: 2019-04-09Updated: 2020-03-19